Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Top Headlines

Celltrion plots $33.6bn investment and 1m litre production capacity expansion

Celltrion plans to invest across its pharmaceutical business up to 2030, creating an estimated 110,000 new jobs in the process and launching 20 products.

Dendreon extends lease on cell therapy plant to 2030

Dendreon Pharmaceuticals has extended the lease on its immunotherapy manufacturing facility in California through to 2030.

Small businesses the ‘bedrock’ that allow for innovation

There are 1,500 SME medicine discovery companies in the UK and more than half are working on non-small molecule therapeutics, a Catapult report finds.

Roche suffers third delay on Spark deal

Roche’s acquisition of Spark was announced at the start of the year but closing the deal has proved difficult after a third delay incurred to give the FTC extra review time.

WuXi Biologics to build 1.3m-sq-ft manufacturing centre

WuXi Biologics announces its latest expansion, with plans for a drug development and commercial manufacturing site with a potential bioreactor capacity of 144,000L.